JP2025509988A5 - - Google Patents

Info

Publication number
JP2025509988A5
JP2025509988A5 JP2024556189A JP2024556189A JP2025509988A5 JP 2025509988 A5 JP2025509988 A5 JP 2025509988A5 JP 2024556189 A JP2024556189 A JP 2024556189A JP 2024556189 A JP2024556189 A JP 2024556189A JP 2025509988 A5 JP2025509988 A5 JP 2025509988A5
Authority
JP
Japan
Prior art keywords
degrees
compound
phenylethynyl
oxazolidine
chlorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024556189A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025509988A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/015966 external-priority patent/WO2023183428A1/en
Publication of JP2025509988A publication Critical patent/JP2025509988A/ja
Publication of JP2025509988A5 publication Critical patent/JP2025509988A5/ja
Pending legal-status Critical Current

Links

JP2024556189A 2022-03-22 2023-03-22 Ｍｇｌｕｒ５調節化合物、組成物、及び使用方法 Pending JP2025509988A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263322446P 2022-03-22 2022-03-22
US63/322,446 2022-03-22
PCT/US2023/015966 WO2023183428A1 (en) 2022-03-22 2023-03-22 Mglur5 modulating compounds, compositions, and methods of use

Publications (2)

Publication Number Publication Date
JP2025509988A JP2025509988A (ja) 2025-04-11
JP2025509988A5 true JP2025509988A5 (https=) 2026-03-31

Family

ID=88101942

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024556189A Pending JP2025509988A (ja) 2022-03-22 2023-03-22 Ｍｇｌｕｒ５調節化合物、組成物、及び使用方法

Country Status (9)

Country Link
US (1) US20250230149A1 (https=)
EP (1) EP4496572A4 (https=)
JP (1) JP2025509988A (https=)
KR (1) KR20250008042A (https=)
CN (1) CN119300827A (https=)
AU (1) AU2023238896A1 (https=)
CA (1) CA3246263A1 (https=)
IL (1) IL315809A (https=)
WO (1) WO2023183428A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025080252A1 (en) * 2023-10-13 2025-04-17 Allyx Therapeutics, Inc. Methods of use of (4r,5r)-5-(2-chlorophenyl)-4-(5-(phenylethynyl)pyridin-3-yl)oxazolidin-2-one
WO2025188734A1 (en) * 2024-03-06 2025-09-12 Allyx Therapeutics, Inc. Methods of use of (4r,5r)-5-(2-chlorophenyl)-4-(5-(phenylethynyl)pyridin-3-yl)oxazolidin-2-one

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691821B2 (en) * 2010-11-11 2014-04-08 Bristol-Myers Squibb Company Oxazolidinones as modulators of mGluR5

Similar Documents

Publication Publication Date Title
US12419877B2 (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
JP2025509988A5 (https=)
US20050203299A1 (en) Methods of preparing aripiprazole crystalline forms
NO312513B1 (no) Mesylat-trihydrat av 5-(2-(4-(1,2-benzoisotiazol-3-yl)-1- piperazinyl)-etyl)-6-klor-1,3-dihydro-2H-indol-2-on(=ziperasidone), og farmasöytisk blanding for behandling avpsykotisk forstyrrelse
EP1660465B1 (en) Process for the synthesis of biaryl oxazolidinones
JP2020073513A (ja) α，ω‐二置換ジヒドロキシシクロペンチル化合物の固体形態、並びにその製造及び使用方法
CN107698574B (zh) 一种高纯度阿瑞匹坦的精制制备工艺
JP2021529805A5 (https=)
US8895741B2 (en) Process for the synthesis of biaryl oxazolidinones
WO2017145089A1 (en) Crystalline form x of bosutinib
TWI659041B (zh) 類固醇樣化合物之多晶型形式以及其製備方法及用途
HK40015773A (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
TW202606675A (zh) {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式，其組合物及用途